-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Cocrystal Pharma, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2018.
- Cocrystal Pharma, Inc. Depreciation for the quarter ending March 31, 2023 was $45K.
- Cocrystal Pharma, Inc. annual Depreciation for 2018 was $50K, a 50.5% decline from 2017.
- Cocrystal Pharma, Inc. annual Depreciation for 2017 was $101K, a 49.8% decline from 2016.
- Cocrystal Pharma, Inc. annual Depreciation for 2016 was $201K, a 4.69% increase from 2015.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)